Form 4: Roivant Sciences CFO Richard Pulik Reports Stock and Option Awards

Richard Pulik, CFO of Roivant Sciences, reports the acquisition of restricted stock units and stock options.

Summary

• Richard Pulik, the CFO of Roivant Sciences Ltd., filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the acquisition of 38,685 restricted stock units (RSUs) with a vesting commencement date of April 20, 2024.
• These RSUs vest 1/4 on the date thirteen (13) months from the vesting commencement date, with the balance vesting in twelve (12) successive equal quarterly installments.
• Pulik also received stock options to purchase 302,594 Common Shares with a vesting commencement date of April 20, 2024.
• These options vest 25% on the first anniversary of the vesting commencement date and then in 36 equal monthly installments thereafter.
• Following these transactions, Pulik beneficially owns 297,382 Common Shares and 302,594 derivative securities.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of executive compensation, which is generally viewed neutrally to positively as it aligns management interests with shareholders.

Positives

• The award of RSUs and stock options to the CFO aligns his interests with those of the shareholders.
• The vesting schedules encourage long-term commitment from the CFO.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders may view the granting of stock options and RSUs as a positive sign, aligning management's interests with the company's long-term success.
• Employees may see this as a standard practice for executive compensation.

Key Dates